Navigation Links
Mother's immunosuppressive medications not likely to put fetus at risk
Date:11/8/2013

Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism.

The paper is one of the first to describe risks for medications used to treat autoimmune diseases when taken during pregnancy, according to first author William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and professor of Health Policy at Monroe Carell Jr. Children's Hospital at Vanderbilt in Nashville, Tenn.

"This study is important because these conditions affect nearly 4.5 million persons in the U.S., including many women of childbearing age," Cooper said. "Currently, there are almost no data to guide women who are pregnant, or planning to become pregnant, who may need to continue their medications during pregnancy."

Study authors used health plan data from Tennessee Medicaid, Kaiser Permanente Northern California and Southern California, linked with vital records and medical records. The three geographically diverse health plans collectively provide coverage for more than 8 million persons each year.

The cohort included 608 infants, including 437 with exposure during pregnancy and 171 whose mothers filled prescriptions for immunosuppressives before, but not during, pregnancy.

Women with rheumatoid and psoriatic arthritis, ankylosing spondylitis, lupus, scleroderma, and inflammatory bowel disease who filled prescriptions for immunosuppressive treatments during pregnancy were included in the study.

The drugs studied included hydroxychloroquine, tumor necrosis factor (TNF) inhibitors and other immunosuppressives such as sulfasalazine and azathioprine.

When compared with the women who had medication treatment before, but not during, pregnancy the risk ratios for adverse fetal outcomes associated with immunosuppressive use during pregnancy were not statistically significant, the authors reported.

Cooper said some of the medications in the study are relatively new and therefore haven't been extensively used in pregnancy. As use continues to expand, follow-up studies will be important to ensure that new safety signals aren't detected.

"One of the things we find in studying drug exposures in pregnancy is that, because up to 50 percent of pregnancies are unplanned, women may be taking a medication and become pregnant while still taking a potentially harmful drug," Cooper said. "Therefore, it's very important for women who have conditions that require medical treatments to talk with their providers about potential risks of medications in pregnancy."


'/>"/>

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Related medicine news :

1. Concerns about MRSA for expectant mothers may be unfounded
2. Low-Income Mothers May Overfeed Their Infants
3. Canadian teen moms run higher risk of abuse, depression than older mothers
4. Study finds that single mothers can reduce stress by playing, engaging with children
5. Study suggests poor mothers favor daughters
6. Making bad worse for expectant mothers
7. New hospital guidelines to help mothers at risk of postpartum depression
8. Lower iron levels seen in newborns of obese mothers
9. Babies Born to Obese Mothers May Have Low Iron: Study
10. Study Ties Infant Birth Weight to Mothers Breast Cancer Risk
11. Pregnant Mothers Gut Changes May Support Fetal Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2018)... ... 15, 2018 , ... On July 30, more than 250 people attended Calvary ... Country Club in Westchester County. The event raised over $300,000 for Calvary programs and ... event included a performance by mentalist and comedian Eric Dittelman, a live auction, silent ...
(Date:8/14/2018)... ... August 14, 2018 , ... Smile Brands Inc. ... affiliated offices across 16 states, is pleased to announce its latest partnership with ... Brands will provide full-service administrative support to the practice, including; purchasing, payroll, accounting, ...
(Date:8/11/2018)... ... August 10, 2018 , ... TopConsumerReviews.com ... Relief. , What is gout? This painful, persistent condition originates in the liver ... high levels of uric acid. Other contributing factors may be medication side effects, ...
(Date:8/9/2018)... ... 2018 , ... Thousands of US women with FDA-approved silicone ... from The American Society of Plastic Surgeons (ASPS), The American Society for Aesthetic ... As an MRI is recommended by FDA after the first three years then ...
(Date:8/9/2018)... ... August 09, 2018 , ... ... as an Operating Partner and will have an exclusive relationship with the firm. ... the firm’s strategic planning, human capital sourcing, and deal origination, evaluation and diligence. ...
Breaking Medicine News(10 mins):
(Date:8/2/2018)... ... August 02, 2018 , ... ... smile for custom crown lengthening treatment at his Eden Prairie, MN ... and an unsteady self-conscious. Using decades of experience, Dr. Sanchez is excited to ...
(Date:8/2/2018)... ... 2018 , ... Clay and Associates DDS, PLC is excited to welcome Dr. ... Dr. John Clay and Dr. Shaun O’Neill as an associate dentist to the practice. ... their patients' dental hygiene, encapsulates the core values of the professional dental team at ...
(Date:8/2/2018)... DUBLIN, Ohio (PRWEB) , ... ... ... , a single collaboration platform with customer relationship management (CRM), patient experience ... accreditation through the DirectTrust Accreditation Program for Health Information Service Providers (HISPs). ...
Breaking Medicine Technology: